Tetracaine powder, a well - known local anesthetic, has a wide range of applications in the medical and cosmetic industries. As a reliable tetracaine powder supplier, I am often asked about how this powder is formulated into different products. In this blog, I will delve into the various processes and considerations involved in formulating tetracaine powder into different end - products.
Product Code: BM-2-5-001
CAS Number: 94-24-6
Molecular formula: C15H24N2O2
Molecular weight: 264.36
Enterprise standard: HPLC>99.5%, HNMR
Main market: USA, Australia, Brazil, Japan, Germany, Indonesia, UK, New Zealand , Canada etc.
Manufacturer: BLOOM TECH Yinchuan Factory
Technology service: R&D Dept.-1
Usage: Standard substance for analysis, Pharmacokinetic study
We provide Pure Tetracaine CAS 94-24-6, please refer to the following website for detailed specifications and product information.
Product:https://www.bloomtechz.com/synthetic-chemical/api-researching-only/pure-tetracaine-cas-94-24-6.html
Understanding Tetracaine Powder
Tetracaine, also known as amethocaine, is a potent ester - type local anesthetic. It works by blocking the generation and conduction of nerve impulses, thereby providing a numbing effect. The powder form of tetracaine is highly pure and can be used as a raw material for formulating different products. Its solubility in water and other solvents, along with its stability under certain conditions, makes it suitable for a variety of formulations.
Formulation into Topical Creams and Gels
One of the most common ways to use tetracaine powder is to formulate it into topical creams and gels. These products are widely used in dermatology, minor surgical procedures, and cosmetic treatments to numb the skin.
The first step in formulating a topical cream or gel is to select the appropriate base. The base can be either oil - in - water (O/W) or water - in - oil (W/O) emulsion, depending on the desired properties of the final product. For example, an O/W emulsion is generally preferred for its light texture and good spreadability on the skin.
The tetracaine powder is then dissolved in a suitable solvent. For water - based formulations, water or a combination of water and other hydrophilic solvents can be used. For oil - based formulations, solvents such as propylene glycol or glycerin may be more appropriate. The concentration of tetracaine in the final product usually ranges from 0.5% to 4%, depending on the intended use.
After dissolving the tetracaine powder, other ingredients are added to the formulation. These may include emulsifiers to stabilize the emulsion, preservatives to prevent microbial growth, and thickeners to adjust the viscosity of the cream or gel. For instance, cetyl alcohol and stearic acid are commonly used as emulsifiers, while parabens or benzyl alcohol can serve as preservatives. Carbomers are often used as thickeners to give the gel its desired consistency.
Once all the ingredients are added, the mixture is homogenized to ensure a uniform distribution of the tetracaine and other components. This can be achieved using high - shear mixers or homogenizers. The final product is then filled into appropriate containers, such as tubes or jars, and labeled with the necessary information, including the concentration of tetracaine, usage instructions, and expiration date.
Formulation into Injectable Solutions
Tetracaine can also be formulated into injectable solutions for use in regional anesthesia. Injectable solutions require a higher level of purity and sterility compared to topical products.
The first step in formulating an injectable tetracaine solution is to dissolve the tetracaine powder in a suitable solvent, usually sterile water for injection. The pH of the solution needs to be carefully adjusted to ensure the stability of the tetracaine. A pH range of 4 - 6 is typically preferred for tetracaine injectable solutions.
Buffers are often added to the solution to maintain the desired pH. For example, phosphate buffers can be used to achieve a stable pH environment. In addition, antioxidants may be added to prevent the oxidation of tetracaine. Sodium bisulfite is a commonly used antioxidant in injectable solutions.
The solution is then filtered through a 0.22 - micron or 0.45 - micron filter to remove any particulate matter. This step is crucial for ensuring the safety of the injectable product. After filtration, the solution is filled into ampoules or vials under aseptic conditions. The filled containers are then sealed and sterilized, usually by autoclaving or using other appropriate sterilization methods.
Formulation into Ophthalmic Preparations
Tetracaine is also used in ophthalmic preparations, such as eye drops. Ophthalmic preparations have strict requirements for purity, sterility, and compatibility with the eye tissues.
To formulate tetracaine eye drops, the tetracaine powder is first dissolved in a sterile aqueous solution. The solution is formulated to be isotonic with the tears of the eye to minimize irritation. This is usually achieved by adding sodium chloride or other tonicity - adjusting agents.
The pH of the eye drops is also carefully controlled. A pH range of 6 - 8 is generally considered suitable for ophthalmic use. Buffers, such as borate buffers, can be used to maintain the desired pH.
Preservatives are added to prevent microbial growth in the eye drops. However, the choice of preservative is limited due to the potential irritation to the eye. Benzalkonium chloride is a commonly used preservative in ophthalmic preparations, but its concentration needs to be carefully controlled.
The formulated eye drops are filtered through a 0.2 - micron filter to ensure sterility. They are then filled into sterile, single - use or multi - use containers, such as dropper bottles.
Regulatory Considerations
When formulating tetracaine powder into different products, it is essential to comply with relevant regulatory requirements. In many countries, tetracaine is a controlled substance, and its production, distribution, and use are strictly regulated.
For example, in the United States, the Food and Drug Administration (FDA) regulates the manufacturing, labeling, and marketing of tetracaine - containing products. Manufacturers need to obtain the necessary approvals and follow good manufacturing practices (GMP) to ensure the quality and safety of the products.
In addition, the concentration of tetracaine in different products is also regulated. Excessive use of tetracaine can lead to serious side effects, such as systemic toxicity and allergic reactions. Therefore, it is crucial to follow the recommended dosage and application guidelines.
Market Trends and Future Outlook
The demand for tetracaine - containing products is expected to grow in the coming years, especially in the medical and cosmetic fields. In the medical field, the increasing number of surgical procedures and minimally invasive treatments will drive the demand for local anesthetics. In the cosmetic field, the popularity of aesthetic procedures, such as tattooing and laser treatments, will also contribute to the growth of the market.
As a tetracaine powder supplier, I am committed to providing high - quality tetracaine powder to meet the needs of different customers. Our powder is produced using advanced manufacturing processes and strict quality control measures to ensure its purity and consistency.
In addition to tetracaine powder, we also offer other related products, such as 5-Fluorouracil API CAS 51-21-8, Procaine Hydrochloride CAS 51-05-8, and Pyridine Hydrochloride CAS 628-13-7. These products are also used in various research and manufacturing applications.
If you are interested in purchasing tetracaine powder or any of our other products, or if you have any questions about product formulation or regulatory compliance, please feel free to contact us. We are more than happy to discuss your requirements and provide you with the best solutions.
Our product form
References
- Handbook of Pharmaceutical Excipients, edited by Raymond C. Rowe, Paul J. Sheskey, and Marian E. Quinn.
- Remington: The Science and Practice of Pharmacy, by Alfonso R. Gennaro.
- Pharmacopoeias of different countries, such as the United States Pharmacopeia (USP) and the European Pharmacopoeia (Ph. Eur.).